ArticlePlant biotechnology journal2025
Ripening-induced defence signalling in Botrytis cinerea-infected tomato fruits involves activation of ERF.F4 by a MYC2-NOR/RIN protein complex.
Article in Plant biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- GhCOR27 confers Verticillium wilt resistance in cotton by relieving the GhASIL1-GhERF114-mediated repression of lignin accumulation.Plant physiology · 2026Article
- Bifunctional transcription factors: recent advances in growth and development, stress resistance, and quality formation of fruits and vegetables.Horticulture research · 2026Article
- The role of induced resistance in mitigating postharvest fungal diseases in fruits and vegetables.Journal of advanced research · 2026Review
- Multi-Omics Analysis Identifies SlLhcb13 as a Key Regulator of Tomato Resistance toPlants (Basel, Switzerland) · 2026Article
- Rewiring of auxin and MAPK signaling is associated with contrasting shoestring and fern-like manifestations in ToBRFV-A134T-infected tomato.Frontiers in plant science · 2026Article
- Tomato activates ethylene signaling to maintainFrontiers in plant science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Fleshy fruits are commercially and nutritionally important but become more susceptible to pathogens as they ripen. Active defence mechanisms continue to function in ripe fruits but they are influenced by ripening regulators and ripening outcomes. Botrytis cinerea is one of the most important fruit fungal pathogens of tomato and jasmonic acid (JA) is the major defence phytohormone involved in response to B. cinerea infection. Pathogens induce the accumulation of bioactive jasmonoyl-isoleucine (JA-Ile), which transmits defence signals through a hub transcription factor (TF) MYC2 that regulates defence responses. This has been clarified in depth in leaves, but how ripening, and in particular the regulators NOR and RIN influence JA-Ile-mediated defence responses remains unclear. In this article, we demonstrate that knocking-out NOR or RIN either singly (CR-NOR, CR-RIN) or together (CR-NOR/RIN) weakens JA-Ile accumulation in response to B. cinerea infection in tomato fruit. Both NOR and RIN physically interact with MYC2, and 110 of 569 differentially expressed genes (DEGs) in B. cinerea-infected wild-type (WT) fruits were identified as direct targets of MYC2. These included ethylene response factors (ERFs) such as ERF.A2, B12, C3, F4, G2/PTI6, whose transcripts accumulated in WT but were greatly reduced in either CR-NOR or CR-RIN infected fruits. Only MYC2 binding to ERF.F4 was severely impaired in CR-NOR and CR-RIN fruits. ERF.F4 transactivates PR-STH2 and activates defence signalling in B. cinerea-infected fruit. The increase in susceptibility to infection caused by promotion of ripening by RIN and NOR is thus partially compensated by their positive action in defence signalling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.